314.12
price down icon2.73%   -8.82
after-market 시간 외 거래: 314.00 -0.12 -0.04%
loading
전일 마감가:
$322.94
열려 있는:
$322.32
하루 거래량:
406.95K
Relative Volume:
1.04
시가총액:
$14.38B
수익:
$2.76B
순이익/손실:
$1.11B
주가수익비율:
13.80
EPS:
22.77
순현금흐름:
$898.10M
1주 성능:
+3.19%
1개월 성능:
-15.75%
6개월 성능:
-8.31%
1년 성능:
+34.26%
1일 변동 폭
Value
$313.98
$324.57
1주일 범위
Value
$299.47
$324.57
52주 변동 폭
Value
$221.53
$417.81

유나이티드 테라퓨틱스 Stock (UTHR) Company Profile

Name
명칭
United Therapeutics Corp
Name
전화
(301) 608-9292
Name
주소
1000 SPRING ST, SILVER SPRING, MD
Name
직원
1,305
Name
트위터
Name
다음 수익 날짜
2024-10-30
Name
최신 SEC 제출 서류
Name
UTHR's Discussions on Twitter

UTHR을(를) 다른 주식과 비교

주식 가격 시가총액 매출 순이익 현금흐름 주당 순 이익
Biotechnology icon
UTHR
United Therapeutics Corp
314.12 14.38B 2.76B 1.11B 898.10M 22.77
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
512.23 130.97B 11.02B -535.60M -978.00M -2.20
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
664.96 73.86B 14.20B 4.41B 3.54B 38.28
Biotechnology icon
ARGX
Argen X Se Adr
611.18 37.38B 2.19B 833.04M -1.28B 12.71
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
244.30 32.70B 2.25B -278.16M -42.59M -2.17
Biotechnology icon
ONC
Beigene Ltd Adr
261.38 27.92B 3.32B -860.46M -1.04B -8.32

유나이티드 테라퓨틱스 Stock (UTHR) Upgrades & Downgrades

날짜 액션 분석자 등급 변경
2024-07-11 다운그레이드 Morgan Stanley Overweight → Equal-Weight
2024-02-12 업그레이드 Goldman Sell → Neutral
2024-02-05 개시 Leerink Partners Outperform
2023-12-08 개시 Wells Fargo Overweight
2022-12-06 개시 UBS Buy
2022-12-05 개시 Goldman Sell
2022-10-11 개시 Morgan Stanley Overweight
2022-09-20 재확인 BofA Securities Underperform
2022-09-19 재개 Wedbush Outperform
2022-02-11 개시 BTIG Research Neutral
2021-07-14 업그레이드 Argus Hold → Buy
2021-04-26 재개 Credit Suisse Outperform
2021-02-01 업그레이드 H.C. Wainwright Neutral → Buy
2020-09-14 재개 JP Morgan Overweight
2020-06-25 재확인 H.C. Wainwright Neutral
2020-03-10 업그레이드 Jefferies Hold → Buy
2020-02-27 업그레이드 Cowen Market Perform → Outperform
2020-01-31 업그레이드 JP Morgan Neutral → Overweight
2019-12-03 개시 BofA/Merrill Underperform
2019-08-01 업그레이드 Jefferies Underperform → Hold
2019-08-01 업그레이드 Ladenburg Thalmann Neutral → Buy
2019-07-01 업그레이드 Credit Suisse Neutral → Outperform
2019-05-17 업그레이드 UBS Sell → Neutral
2019-05-09 업그레이드 Credit Suisse Underperform → Neutral
2018-10-12 업그레이드 Standpoint Research Hold → Buy
2018-08-08 다운그레이드 Credit Suisse Neutral → Underperform
2018-04-03 업그레이드 Credit Suisse Underperform → Neutral
2018-02-22 재확인 Barclays Underweight
2018-01-18 재개 Credit Suisse Underperform
2017-12-27 재확인 Wedbush Outperform
2017-04-27 재확인 Wedbush Outperform
2017-03-30 개시 UBS Sell
2017-03-16 개시 Credit Suisse Underperform
모두보기

유나이티드 테라퓨틱스 주식(UTHR)의 최신 뉴스

pulisher
Mar 14, 2025

Is United Therapeutics Corporation (UTHR) the Best Healthcare Stock For Long-Term Investment? - Insider Monkey

Mar 14, 2025
pulisher
Mar 12, 2025

United Therapeutics president Michael Benkowitz sells $640k in stock By Investing.com - Investing.com Australia

Mar 12, 2025
pulisher
Mar 11, 2025

For patients needing transplants, hope arrives on tiny hooves - The Spokesman Review

Mar 11, 2025
pulisher
Mar 11, 2025

United Therapeutics president Michael Benkowitz sells $640k in stock - Investing.com

Mar 11, 2025
pulisher
Mar 04, 2025

What Will United Therapeutics Reveal at the Leerink Conference? Key Details for Investors - StockTitan

Mar 04, 2025
pulisher
Mar 03, 2025

Top Executives Cash In on United Therapeutics Stock! - TipRanks

Mar 03, 2025
pulisher
Mar 03, 2025

Ray Kurzweil Sells 15,000 Shares of United Therapeutics Corp - GuruFocus.com

Mar 03, 2025
pulisher
Mar 03, 2025

United Therapeutics director Thompson sells $795,837 in stock By Investing.com - Investing.com Canada

Mar 03, 2025
pulisher
Mar 03, 2025

United Therapeutics director Thompson sells $795,837 in stock - Investing.com India

Mar 03, 2025
pulisher
Mar 03, 2025

Silver Spring's United Therapeutics to Begin Clinical Study of Groundbreaking UKidney™ (Pig Organ) Transplant - The MoCoShow

Mar 03, 2025
pulisher
Mar 03, 2025

Q2 EPS Estimate for United Therapeutics Lowered by Analyst - Defense World

Mar 03, 2025
pulisher
Mar 01, 2025

Oppenheimer Asset Management Inc. Sells 6,988 Shares of United Therapeutics Co. (NASDAQ:UTHR) - MarketBeat

Mar 01, 2025
pulisher
Mar 01, 2025

Bank of New York Mellon Corp Sells 1,693 Shares of United Therapeutics Co. (NASDAQ:UTHR) - MarketBeat

Mar 01, 2025
pulisher
Mar 01, 2025

United Therapeutics (NASDAQ:UTHR) Earns “Buy” Rating from HC Wainwright - Defense World

Mar 01, 2025
pulisher
Mar 01, 2025

United Therapeutics Co. (NASDAQ:UTHR) Shares Sold by New York State Common Retirement Fund - MarketBeat

Mar 01, 2025
pulisher
Feb 28, 2025

Weil Company Inc. Has $449,000 Position in United Therapeutics Co. (NASDAQ:UTHR) - MarketBeat

Feb 28, 2025
pulisher
Feb 28, 2025

United Therapeutics (NASDAQ:UTHR) Releases Earnings Results, Beats Expectations By $0.09 EPS - MarketBeat

Feb 28, 2025
pulisher
Feb 28, 2025

United Therapeutics (NASDAQ:UTHR) Shares Gap Down Following Insider Selling - MarketBeat

Feb 28, 2025
pulisher
Feb 28, 2025

United Therapeutics Co. (NASDAQ:UTHR) Stock Position Boosted by Fjarde AP Fonden Fourth Swedish National Pension Fund - MarketBeat

Feb 28, 2025
pulisher
Feb 28, 2025

United Therapeutics (NASDAQ:UTHR) Releases Quarterly Earnings Results, Beats Expectations By $0.09 EPS - MarketBeat

Feb 28, 2025
pulisher
Feb 28, 2025

Los Angeles Capital Management LLC Has $36.55 Million Stake in United Therapeutics Co. (NASDAQ:UTHR) - MarketBeat

Feb 28, 2025
pulisher
Feb 28, 2025

Truist Financial Corp Sells 2,920 Shares of United Therapeutics Co. (NASDAQ:UTHR) - MarketBeat

Feb 28, 2025
pulisher
Feb 28, 2025

United Therapeutics Co. (NASDAQ:UTHR) COO Michael Benkowitz Sells 10,000 Shares - MarketBeat

Feb 28, 2025
pulisher
Feb 28, 2025

Atria Wealth Solutions Inc. Invests $412,000 in United Therapeutics Co. (NASDAQ:UTHR) - Defense World

Feb 28, 2025
pulisher
Feb 27, 2025

United Therapeutics Corp. Reports Record Revenue and Growth - TipRanks

Feb 27, 2025
pulisher
Feb 27, 2025

United Therapeutics Corp. to Host Earnings Call - ACCESS Newswire

Feb 27, 2025
pulisher
Feb 27, 2025

United Therapeutics Reports Record Revenue in Q4 2024, Advances Strategic Growth - HPBL

Feb 27, 2025
pulisher
Feb 27, 2025

United Therapeutics Corporation (NASDAQ:UTHR) Q4 2024 Earnings Call Transcript - Insider Monkey

Feb 27, 2025
pulisher
Feb 27, 2025

Goldman Sachs cuts United Therapeutics stock target to $293 By Investing.com - Investing.com Australia

Feb 27, 2025
pulisher
Feb 27, 2025

Goldman Sachs cuts United Therapeutics stock target to $293 - Investing.com

Feb 27, 2025
pulisher
Feb 27, 2025

United Therapeutics: Q4 Earnings Snapshot - Thehour.com

Feb 27, 2025
pulisher
Feb 27, 2025

United Therapeutics Corp (UTHR) Q4 2024 Earnings Call Highlights: Record Revenue and Strategic ... - Yahoo Finance

Feb 27, 2025
pulisher
Feb 27, 2025

Decoding United Therapeutics Corp (UTHR): A Strategic SWOT Insig - GuruFocus.com

Feb 27, 2025
pulisher
Feb 27, 2025

United Therapeutics Reports Record 2024 Financial Results - TipRanks

Feb 27, 2025
pulisher
Feb 26, 2025

United Therapeutics Enters Oversold Territory (UTHR) - Nasdaq

Feb 26, 2025
pulisher
Feb 26, 2025

United Therapeutics (UTHR) Shares Cross Below 200 DMA - Nasdaq

Feb 26, 2025
pulisher
Feb 26, 2025

United Therapeutics Stock Down Despite Q4 Earnings & Sales Beat - Yahoo Finance

Feb 26, 2025
pulisher
Feb 26, 2025

Earnings call transcript: United Therapeutics Q4 2024 earnings miss impacts stock - Investing.com

Feb 26, 2025
pulisher
Feb 26, 2025

United Therapeutics (NASDAQ:UTHR) Reports Q4 In Line With Expectations - Yahoo Finance

Feb 26, 2025
pulisher
Feb 26, 2025

United Therapeutics: Q4 Earnings Snapshot -February 26, 2025 at 06:49 am EST - Marketscreener.com

Feb 26, 2025
pulisher
Feb 26, 2025

United Therapeutics Corporation Reports Fourth Quarter and Full Year 2024 Financial Results - TradingView

Feb 26, 2025
pulisher
Feb 26, 2025

UNITED THERAPEUTICS Corp SEC 10-K Report - TradingView

Feb 26, 2025
pulisher
Feb 26, 2025

GraniteShares Advisors LLC Takes Position in United Therapeutics Co. (NASDAQ:UTHR) - MarketBeat

Feb 26, 2025
pulisher
Feb 26, 2025

How United Therapeutics Drove 24% Revenue Growth in 2024Key Products and Pipeline Updates - StockTitan

Feb 26, 2025
pulisher
Feb 25, 2025

What To Expect From United Therapeutics’s (UTHR) Q4 Earnings - Yahoo Finance

Feb 25, 2025
pulisher
Feb 25, 2025

United Therapeutics: A Unique Business With High Margins And Expansion Potential - Seeking Alpha

Feb 25, 2025
pulisher
Feb 24, 2025

Seeking Clues to United Therapeutics (UTHR) Q4 Earnings? A Peek Into Wall Street Projections for Key Metrics - Yahoo Finance

Feb 24, 2025
pulisher
Feb 24, 2025

United Therapeutics Corp expected to post earnings of $6.31 a shareEarnings Preview - TradingView

Feb 24, 2025
pulisher
Feb 24, 2025

Can United Therapeutics' Next Strategic Move Transform Patient Care? Key Insights Coming March 3 - StockTitan

Feb 24, 2025
pulisher
Feb 23, 2025

United Therapeutics Corporation (UTHR): Among Renaissance Technologies Portfolio’s Top Stock Picks - Insider Monkey

Feb 23, 2025
pulisher
Feb 21, 2025

Vontobel Holding Ltd. Cuts Position in United Therapeutics Co. (NASDAQ:UTHR) - Defense World

Feb 21, 2025

유나이티드 테라퓨틱스 (UTHR) 재무 분석

매출

loading

순이익

loading

현금흐름

loading

주당 순 이익

loading

유나이티드 테라퓨틱스 주식 (UTHR) 내부자 거래

내부자 거래 관계 날짜 거래 비용 #주식 가치 ($) #주식 총계
BENKOWITZ MICHAEL
PRESIDENT AND COO
Mar 10 '25
Sale
320.09
2,000
640,184
0
$33.41
price up icon 1.18%
$19.83
price down icon 1.49%
$76.99
price down icon 1.00%
$100.36
price down icon 0.50%
biotechnology ONC
$261.38
price down icon 1.39%
자본화:     |  볼륨(24시간):